Stock Earnings

Question 1

Esperion Therapeutics Inc의 주요 재무제표는 무엇인가요?

Accepted Answer

최신 재무제표(Form-10K)에 따르면, Esperion Therapeutics Inc의 총 자산은 $343이며, 순loss입니다.

Question 2

ESPR의 주요 재무 비율은 무엇인가요?

Accepted Answer

Esperion Therapeutics Inc의 유동비율은 0.46이고, 순이익률은 -15.36, 주당 매출은 $1.77입니다.

Question 3

Esperion Therapeutics Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?

Accepted Answer

Esperion Therapeutics Inc largest revenue segment is Pharmaceutical, at a revenue of 332,314,000 in the most earnings release.For geography, United States is the primary market for Esperion Therapeutics Inc, at a revenue of 332,314,000.

Question 4

Esperion Therapeutics Inc은 수익성이 있나요?

Accepted Answer

no, 최신 재무제표에 따르면 Esperion Therapeutics Inc의 순loss은 $-51입니다.

Question 5

Esperion Therapeutics Inc에 부채가 있나요?

Accepted Answer

yes, Esperion Therapeutics Inc의 부채는 732입니다.

Question 6

Esperion Therapeutics Inc의 발행 주식은 몇 주인가요?

Accepted Answer

Esperion Therapeutics Inc의 총 발행 주식은 195.85주입니다.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	303	332	116	75	78	227
Revenue Growth (YoY)	3%	186%	55%	-4%	-66%	53%
Cost of Revenue	127	68	43	27	14	2
Gross Profit	176	263	73	48	64	225
Selling, General & Admin	161	163	142	109	171	199
Research & Development	44	46	86	118	106	146
Operating Expenses	206	209	228	228	277	346
Other Non Operating Income (Expenses)	0	0	0	0	3	0
Pretax Income	-105	-51	-209	-233	-269	-143
Income Tax Expense	0	--	--	--	--	--
Net Income	-105	-51	-209	-233	-269	-143
Net Income Growth	22%	-76%	-10%	-13%	88%	47%
Shares Outstanding (Diluted)	200.73	187.18	103.1	66.4	28.9	27.5
Shares Change (YoY)	3%	82%	55%	130%	5%	1%
EPS (Diluted)	-0.53	-0.27	-2.02	-3.52	-9.31	-5.23
EPS Growth	22%	-86%	-42%	-62%	78%	46%
Free Cash Flow	-93	-23	-135	-174	-263	-98
Free Cash Flow Per Share	-0.46	-0.12	-1.3	-2.62	-9.1	-3.56
Gross Margin	58.08%	79.21%	62.93%	64%	82.05%	99.11%
Operating Margin	-9.57%	16.26%	-133.62%	-238.66%	-273.07%	-53.3%
Profit Margin	-34.65%	-15.36%	-180.17%	-310.66%	-344.87%	-62.99%
Free Cash Flow Margin	-30.69%	-6.92%	-116.37%	-231.99%	-337.17%	-43.17%
EBITDA	-29	54	-155	-179	-213	-121
EBITDA Margin	-9.57%	16.26%	-133.62%	-238.66%	-273.07%	-53.3%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-29	54	-155	-179	-213	-121
EBIT Margin	-9.57%	16.26%	-133.62%	-238.66%	-273.07%	-53.3%
Effective Tax Rate	0%	--	--	--	--	--

Esperion Therapeutics Inc (ESPR) Price

ESPR Stock Price Chart

ESPR Income

Follow-Up Questions